ETFMG Alternative Harvest ETF (MJ)

16.07 -0.73  -4.35% NYSE Arca Nov 18, 16:59 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 16.75
Discount or Premium to NAV 0.30%
Turnover Ratio 97.00%
1 Year Fund Level Flows --

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -14.37% -14.63% -- --
3M -33.87% -33.98% -- --
6M -49.48% -49.72% -- --
YTD -31.22% -31.22% -- --
1Y -44.06% -45.00% -- --
3Y -10.15% -9.36% -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of Nov. 15, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 1.39% 1.39% 0.00%
Stock 98.61% 98.61% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 15, 2019

Region Exposure

Americas 81.37%
North America 81.37%
Latin America 0.00%
Greater Europe 16.40%
United Kingdom 11.85%
Europe Developed 4.55%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 2.23%
Japan 2.23%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of Nov. 15, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 4.74%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 21.32%
Energy 0.00%
Financial Services 0.00%
Healthcare 71.68%
Industrials 2.26%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Nov. 15, 2019

Stock Market Capitalization

Giant 6.88%
Large 4.55%
Medium 32.53%
Small 25.21%
Micro 30.84%
As of Nov. 15, 2019

Stock Style Exposure

Large Cap Value 12.32%
Large Cap Blend 3.19%
Large Cap Growth 0.00%
Mid Cap Value 0.00%
Mid Cap Blend 3.13%
Mid Cap Growth 31.12%
Small Cap Value 14.46%
Small Cap Blend 3.53%
Small Cap Growth 32.26%
As of Nov. 15, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
TLRY Tilray Inc 7.92% 19.87 -0.30%
GWPH GW Pharmaceuticals PLC ADR 7.20% 102.50 -5.45%
WEED.TO Canopy Growth Corp 6.81% 18.78 -7.44%
CRON.TO Cronos Group Inc 6.79% 8.15 -2.51%
ACB.TO Aurora Cannabis Inc 6.75% 3.00 -16.43%
APHA.TO Aphria Inc 3.80% 5.03 -10.97%
LABS.TO MediPharm Labs Corp 3.71% 3.94 -2.96%
HEXO.TO HEXO Corp 3.69% 2.11 -10.21%
CRBP Corbus Pharmaceuticals Holdings Inc 3.62% 4.37 -1.80%
OGI.TO OrganiGram Holdings Inc 3.05% 2.72 -10.53%
As of Nov. 15, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Alternative Harvest Index. The fund will invest at least 80% of its total assets, exclusive of collateral held from securities lending, in the component securities of the index and in ADRs and GDRs based on the component securities in the index. The index is concentrated in the Pharmaceuticals and Tobacco industries and tracks the performance of the exchange-listed common stock (or corresponding ADRs or GDRs) of companies across the globe. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Miscellaneous Sector
Prospectus Objective Specialty - Unaligned
Fund Owner Firm Name ETFMG
Benchmark Index
Prime Alternative Harvest TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Devin Ryder 1.40 yrs
Donal Bishnoi 0.00 yrs
Frank Vallario 0.00 yrs
Samuel Masucci 1.40 yrs

Net Fund Flows

1M -2.826M
3M 44.64M
6M 87.70M
YTD 366.75M
1Y --
3Y --
5Y --
10Y --
As of Oct. 31, 2019

Risk Info

Beta (5Y) 2.062
Max Drawdown (All) 55.52%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.2097
30-Day Rolling Volatility 41.14%
Daily Value at Risk (VaR) 1% (All) 6.22%
Monthly Value at Risk (VaR) 1% (All) 22.40%

Fundamentals

Dividend Yield TTM (11-18-19) 6.04%
30-Day SEC Yield (11-1-19) 0.00%
7-Day SEC Yield --
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 3.713
Weighted Average Price to Book Ratio 2.039
Weighted Median ROE -15.40%
Weighted Median ROA -14.53%
Forecasted Dividend Yield 2.26%
Forecasted PE Ratio 13.61
Forecasted Price to Sales Ratio 3.059
Forecasted Price to Book Ratio 0.7353
Number of Holdings 40
As of Nov. 15, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.02%
Forecasted Book Value Growth 66.82%
Forecasted Cash Flow Growth -0.16%
Forecasted Earnings Growth 55.14%
Forecasted Revenue Growth 5.66%
As of Nov. 15, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 12/3/2015
Termination Date
Last Annual Report Date 9/30/2018
Last Prospectus Date 1/31/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.